Single Peptide10mgResearch-Based Protocol

Dihexa (10mg) Dosage Protocol

Dihexa is a hexapeptide derived from angiotensin IV that acts as a hepatocyte growth factor (HGF) mimetic. Research indicates potent nootropic effects at very low doses, enhancing synaptic connectivity.

Quickstart Highlights
Reconstitute

Add 10 mL bacteriostatic water → 1 mg/mL (1000 mcg/mL)

Daily Range

10-30mg sublingually or 1-5mg subcutaneously

Easy Measuring

At 1 mg/mL: 10 units = 100 mcg, 100 units = 1mg

Storage

Lyophilized: -20°C; Reconstituted: 2-8°C for up to 4 weeks

Dosing & Reconstitution Guide
Educational guide for reconstitution and daily dosing based on research literature
WeekDaily DoseUnits (per injection)
Sublingual10-30mgOnce daily
Subcutaneous1-5mgOnce daily
Duration4-8 weeksCycle length
Reconstitution Steps
  1. 1Draw 10 mL bacteriostatic water with a sterile syringe
  2. 2Inject slowly down the vial wall to prevent foaming
  3. 3Gently swirl until fully dissolved - do not shake
  4. 4Label with date and concentration, refrigerate immediately
How This Works

Dihexa is an HGF/c-Met receptor agonist that promotes synaptogenesis and dendritic spine formation. Animal studies showed cognitive enhancement at picomolar concentrations (10^7 times more potent than BDNF). It crosses the blood-brain barrier and may support neuroplasticity.

Potential Benefits & Effects
Observations from preclinical and clinical literature
  • Potent nootropic effects in animal studies
  • Promotes synaptogenesis and spine density
  • Crosses blood-brain barrier
  • Active at very low concentrations
Scientific References
Published research supporting this protocol
  1. Benoist CC, et al. Dihexa enhances cognition. J Pharmacol Exp Ther. 2014;349(1):69-78
  2. McCoy AT, et al. Angiotensin IV and cognition. Pharmacol Biochem Behav. 2013;105:51-7
  3. Wright JW, Harding JW. The brain angiotensin system and cognition. Exp Neurol. 2013;239:152-63
Storage Instructions

Lyophilized

Store at -20°C, protected from light

Reconstituted

Refrigerate at 2-8°C, use within 4 weeks

Sublingual administration may have lower bioavailability

Important Notes
  • Research compound - not FDA approved
  • Limited human safety data available
  • Extremely potent - careful dosing required
  • Developed at Washington State University

Disclaimer: This content is intended for research and educational purposes only. Not intended to diagnose, treat, cure, or prevent any disease. All compounds are for research use only. Dosing information is derived from published scientific literature and clinical studies.